Bello Bio –
First rate tissue processing guided by cGMP principles, research driven with a focus on quality
VISION & MISSION
Who We Are?
Bello Bio is a first rate tissue allograft lab that processes ethically acquired birth tissue for use in the following settings:
First rate tissue processing guided by cGMP principles, research driven with a focus on quality
When used in a clinical setting, the birth tissue allografts provide the highest quality tissue to promote safe and predictable results. Bello Bio is FDA Registered in the USA, and follows 1271.150 Current good tissue practice requirements. The continuous air quality management, Biosafety Level 2 Cabinets and screened donor tissue ensures consistency with the tissue quality and clinical/research results, and screened donor tissue ensures consistent, premium quality tissue products.
Bello Bio operates under strict compliance with federal regulations. Bello Bio is located in Scottsdale, Arizona.
Providing our Partners
the Highest Quality Tissue Allografts Available.
About Bello Bio
Consent
The option to donate umbilical cord tissue is offered to expecting mothers by participating hospitals. Mothers who choose to donate undergo a rigorous screening and sign consent forms, indicating they consent to have their umbilical cord tissue used in medicine.
Donation
Umbilical cord tissue and blood extraction is conducted by a qualified individual immediately following delivery. Tissue is then processed in a FDA registered laboratory.
Production
Bello Bio applies FDA regulatory standards to screen umbilical cord tissue for quality, pathogens and disease. We partner with an accredited third party to achieve comprehensive testing/screening.
Sale
Bello Bio only distributes to Regen Suppliers our “exclusive distributor” this also means Bello Bio needs to have an exclusive distribution arrangement” signed with Regen Suppliers. These contracts are required for accreditation.
Contact Regen Suppliers at (888) 568-6909 to get in touch with a representative.
Bello Bio Leadership
President
Manager of Quality and Regulatory Affairs
Chief Science Officer
Medical Director
Operations and Logistics Specialist
Finance and Treasury Coordinator
Get Early Access
Sign up for our email list to keep up to date with all the Bello Bio news and latest happenings!
10045 East Dynamite Boulevard
Suite 260
Scottsdale, AZ 85262
Copyright © 2025 . Bello Bio . All Right Reserved.
This website is intended to inform and educate medical professionals. It is NOT intended for patients. It also does not seek to make claims about the effectiveness of regenerative medicine and its respective therapies in medical treatment.
Regenerative therapies have great potential in helping treat a range of conditions.
This site serves to inform medical professionals about regenerative medicine, Bello Bio allograft products, and key in vitro, animal model, and clinical research studies that have been carried out to date across medical specialties and health conditions. However, regenerative medicine is an early and evolving field.
While the Bello Bio products are produced in an FDA compliant laboratory in the USA, they have not been approved by the FDA for treatment effectiveness. The FDA states:
Like other medical products that are intended to treat, cure or prevent disease, generally require FDA approval before they can be marketed. FDA has not approved any stem cell-based products for use, other than cord blood-derived hematopoietic progenitor cells (blood-forming stem cells) for certain indications.
Patients interested in regenerative therapy in the U.S. are advised to consult a physician about the state of approval for any given product and/or inquire about opportunities to participate in a clinical trial. It is important to be aware that regulations and clinical study requirements vary from country to country.
By clicking yes you confirm that you are a medical professional, understand that the information contained in this website is intended for medical professionals and not for the general public, and have read and understood the disclaimer above.